Science In Financials
| SIS Stock | 28.50 0.00 0.00% |
Science | Select Account or Indicator |
Please note, the presentation of Science In's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Science In's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Science In's management manipulating its earnings.
Science In Stock Summary
Science In competes with Broadcom, Lindsell Train, Sealed Air, Wizz Air, and Norman Broadbent. Science In is entity of United Kingdom. It is traded as Stock on LSE exchange.Specialization | Consumer Defensive, Food, Beverage & Tobacco |
| Instrument | UK Stock View All |
| Exchange | London Exchange |
| ISIN | GB00BBPV5329 |
| Business Address | 16-18 Hatton Garden, |
| Sector | Food Products |
| Industry | Consumer Staples |
| Benchmark | Dow Jones Industrial |
| Website | www.scienceinsport.com |
You should never invest in Science In without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Science Stock, because this is throwing your money away. Analyzing the key information contained in Science In's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Science In Key Financial Ratios
There are many critical financial ratios that Science In's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Science in Sport reports annually and quarterly.| Revenue | 62.67 M | ||||
| Gross Profit | 23.82 M | ||||
| EBITDA | (3.48 M) | ||||
| Net Income | (11.28 M) | ||||
| Total Asset | 70.3 M |
Science In Key Balance Sheet Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Total Assets | 63.0M | 73.9M | 75.7M | 70.3M | 80.8M | 84.9M | |
| Other Current Liab | 5.4M | 6.1M | 8.1M | 9.4M | 10.8M | 11.3M | |
| Net Debt | (9.6M) | 7.6M | 20.8M | 21.7M | 25.0M | 26.2M | |
| Retained Earnings | (16.1M) | (20.1M) | (28.6M) | (41.1M) | (37.0M) | (35.1M) | |
| Accounts Payable | 5.4M | 7.6M | 5.0M | 5.1M | 5.9M | 3.1M | |
| Cash | 10.5M | 4.9M | 930K | 2.1M | 2.5M | 2.3M | |
| Net Receivables | 9.8M | 12.7M | 16.5M | 11.3M | 13.0M | 6.6M | |
| Inventory | 7.0M | 8.4M | 6.6M | 6.8M | 7.8M | 4.2M | |
| Other Current Assets | 852.0K | 577.0K | 1.5M | 2.5M | 2.8M | 2.1M | |
| Total Liab | 14.9M | 29.9M | 35.4M | 41.2M | 47.4M | 49.8M | |
| Total Current Assets | 27.3M | 26.0M | 24.1M | 22.7M | 26.1M | 16.0M | |
| Short Term Debt | 209K | 554K | 8.6M | 11.7M | 13.4M | 14.1M | |
| Intangible Assets | 14.7M | 14.3M | 13.3M | 9.6M | 11.1M | 9.6M | |
| Net Tangible Assets | 12.8M | 17.0M | 12.4M | 9.6M | 11.0M | 13.0M | |
| Other Assets | 1.6M | 2.2M | 323K | 1.8M | 2.1M | 1.4M | |
| Net Invested Capital | 48.0M | 45.6M | 51.2M | 42.1M | 48.5M | 47.9M | |
| Net Working Capital | 15.2M | 10.6M | 1.9M | (5.3M) | (4.7M) | (4.5M) |
Science In Key Income Statement Accounts
An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Interest Expense | 79K | 119K | 757K | 1.6M | 1.8M | 1.9M | |
| Total Revenue | 50.4M | 62.5M | 63.8M | 62.7M | 72.1M | 75.7M | |
| Gross Profit | 24.6M | 31.4M | 26.9M | 26.8M | 30.9M | 32.4M | |
| Operating Income | (2.2M) | (5.2M) | (9.8M) | (9.7M) | (8.8M) | (8.3M) | |
| Ebit | (2.3M) | (5.5M) | (10.0M) | (9.7M) | (8.8M) | (8.3M) | |
| Ebitda | 846K | (1.8M) | (5.2M) | (3.5M) | (3.1M) | (3.3M) | |
| Cost Of Revenue | 25.8M | 31.2M | 36.8M | 35.8M | 41.2M | 43.3M | |
| Income Before Tax | (2.3M) | (5.3M) | (10.6M) | (11.3M) | (10.2M) | (9.7M) | |
| Net Income | (1.7M) | (6.8M) | (10.9M) | (11.3M) | (10.2M) | (9.6M) | |
| Income Tax Expense | (545K) | 1.5M | 332K | (12K) | (13.8K) | (13.1K) | |
| Research Development | 383K | 693K | 249K | 464K | 533.6K | 362.8K | |
| Tax Provision | (545K) | 1.5M | 332K | (12K) | (13.8K) | (13.1K) | |
| Net Interest Income | (36K) | (114K) | (757K) | (1.6M) | (1.4M) | (1.3M) |
Science In Key Cash Accounts
Cash flow analysis captures how much money flows into and out of Science in Sport. It measures of how well Science is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Science In brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Science had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Science In has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | (833K) | (1.5M) | 1.8M | (126K) | (144.9K) | (152.1K) | |
| Change In Cash | 5.1M | (5.6M) | (3.9M) | 1.2M | 1.1M | 1.1M | |
| Free Cash Flow | 1.0M | (6.7M) | (16.6M) | 2.1M | 1.9M | 2.0M | |
| Depreciation | 3.2M | 3.6M | 4.8M | 6.3M | 7.2M | 7.5M | |
| Other Non Cash Items | 47K | 112K | 757K | 5.7M | 6.5M | 6.9M | |
| Capital Expenditures | 2.1M | 6.5M | 8.0M | 1.1M | 1.3M | 2.1M | |
| Net Income | (1.7M) | (6.8M) | (10.9M) | (11.3M) | (10.2M) | (9.6M) | |
| End Period Cash Flow | 10.5M | 4.9M | 930K | 2.1M | 2.5M | 2.3M | |
| Change To Netincome | 1.7M | (319K) | 4.5M | 1.4M | 1.6M | 1.5M | |
| Investments | (2.1M) | (6.5M) | (8.0M) | (2.1M) | (2.4M) | (2.6M) |
Science Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Science In's current stock value. Our valuation model uses many indicators to compare Science In value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Science In competition to find correlations between indicators driving Science In's intrinsic value. More Info.Science in Sport is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Science In's earnings, one of the primary drivers of an investment's value.Science in Sport Systematic Risk
Science In's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Science In volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Science in Sport correlated with the market. If Beta is less than 0 Science In generally moves in the opposite direction as compared to the market. If Science In Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Science in Sport is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Science In is generally in the same direction as the market. If Beta > 1 Science In moves generally in the same direction as, but more than the movement of the benchmark.
Science in Sport Total Assets Over Time
Science In Thematic Clasifications
Science in Sport is part of several thematic ideas from Sport Products to Aluminum. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic IdeasScience In March 22, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Science In help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Science in Sport. We use our internally-developed statistical techniques to arrive at the intrinsic value of Science in Sport based on widely used predictive technical indicators. In general, we focus on analyzing Science Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Science In's daily price indicators and compare them against related drivers.
| Downside Deviation | 2.55 | |||
| Information Ratio | 0.117 | |||
| Maximum Drawdown | 9.39 | |||
| Value At Risk | (1.92) | |||
| Potential Upside | 2.27 |
Complementary Tools for Science Stock analysis
When running Science In's price analysis, check to measure Science In's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Science In is operating at the current time. Most of Science In's value examination focuses on studying past and present price action to predict the probability of Science In's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Science In's price. Additionally, you may evaluate how the addition of Science In to your portfolios can decrease your overall portfolio volatility.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |